Literature DB >> 16510123

Purification of a phospholipase A2 from Lonomia obliqua caterpillar bristle extract.

Carla Simone Seibert1, Anita Mitico Tanaka-Azevedo, Marcelo Larami Santoro, Stephen P Mackessy, Ricardo José Soares Torquato, Ivo Lebrun, Aparecida Sadae Tanaka, Ida Sigueko Sano-Martins.   

Abstract

Lonomia obliqua caterpillar bristle extract induces both direct and indirect hemolytic activity on human and rat washed erythrocytes, and provokes intravascular hemolysis in Wistar rats. Indirect hemolytic activity is assumed to be caused by a phospholipase A(2) (PLA(2)) present in this extract, and this investigation was initiated in order to characterize this enzyme. Phospholipase A(2) activity of crude extract was inhibited by both a PLA(2)-specific inhibitor (pBpb) and the metal ion chelator EDTA. L. obliqua PLA(2) was purified by liquid chromatography from the crude bristle extract and had a molecular mass of 15kDa and a pI of 5.9; its N-terminal sequence showed high homology to a sequence of a putative PLA(2) obtained from a cDNA library of L. obliqua bristles, and it is tentatively placed among Group III phospholipases A(2). This enzyme was stable at 4 degrees C, sensitive to higher temperatures, and its maximum catalytic activity was at pH 8.0. L. obliqua PLA(2) induced hemolysis only when incubated with exogenous lecithin. Thus, the PLA(2) purified herein appears to be responsible for the indirect hemolytic activity of the crude bristle extract.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16510123     DOI: 10.1016/j.bbrc.2006.02.071

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Mechanisms of acute kidney injury induced by experimental Lonomia obliqua envenomation.

Authors:  Markus Berger; Lucélia Santi; Walter O Beys-da-Silva; Fabrício Marcus Silva Oliveira; Marcelo Vidigal Caliari; John R Yates; Maria Aparecida Ribeiro Vieira; Jorge Almeida Guimarães
Journal:  Arch Toxicol       Date:  2014-05-06       Impact factor: 5.153

2.  Lonomia obliqua venomous secretion induces human platelet adhesion and aggregation.

Authors:  Markus Berger; José Reck; Renata M S Terra; Walter O Beys da Silva; Lucélia Santi; Antônio F M Pinto; Marilene H Vainstein; Carlos Termignoni; Jorge A Guimarães
Journal:  J Thromb Thrombolysis       Date:  2010-10       Impact factor: 2.300

Review 3.  Helminthes and insects: maladies or therapies.

Authors:  Nora L El-Tantawy
Journal:  Parasitol Res       Date:  2014-12-30       Impact factor: 2.289

4.  Effects of Lonomia obliqua caterpillar venom upon the proliferation and viability of cell lines.

Authors:  Tiago Elias Heinen; Caroline Brunetto de Farias; Ana Lucia Abujamra; Ronaldo Zucatelli Mendonça; Rafael Roesler; Ana Beatriz Gorini da Veiga
Journal:  Cytotechnology       Date:  2013-01-22       Impact factor: 2.058

5.  Premolis semirufa (Walker, 1856) envenomation, disease affecting rubber tappers of the Amazon: searching for caterpillar-bristles toxic components.

Authors:  Isadora Maria Villas-Boas; Rute Maria Gonçalves-de-Andrade; Giselle Pidde-Queiroz; Suely Lucia Muro Rais Assaf; Fernanda C V Portaro; Osvaldo A Sant'Anna; Carmen W van den Berg; Denise V Tambourgi
Journal:  PLoS Negl Trop Dis       Date:  2012-02-28

6.  Longxuetongluo Capsule Improves Erythrocyte Function against Lipid Peroxidation and Abnormal Hemorheological Parameters in High Fat Diet-Induced ApoE-/- Mice.

Authors:  Jiao Zheng; Binglin Liu; Qixing Lun; Weijuan Yao; Yunfang Zhao; Wei Xiao; Wenzhe Huang; Yonghua Wang; Jun Li; Pengfei Tu
Journal:  Oxid Med Cell Longev       Date:  2015-11-16       Impact factor: 6.543

Review 7.  Lonomia obliqua Envenoming and Innovative Research.

Authors:  Miryam Paola Alvarez-Flores; Renata Nascimento Gomes; Dilza Trevisan-Silva; Douglas Souza Oliveira; Isabel de Fátima Correia Batista; Marcus Vinicius Buri; Angela Maria Alvarez; Carlos DeOcesano-Pereira; Marcelo Medina de Souza; Ana Marisa Chudzinski-Tavassi
Journal:  Toxins (Basel)       Date:  2021-11-23       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.